Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.63 CAD | -.--% | -.--% | -3.08% |
03-21 | LifeSpeak Inc. Reports Q4 2023 Adjusted Loss of $0.05 Per Share | MT |
03-21 | Transcript : LifeSpeak Inc., Q4 2023 Earnings Call, Mar 21, 2024 |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- The company has insufficient levels of profitability.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.08% | 27.29M | - | ||
+7.89% | 320B | B- | ||
+21.67% | 213B | B+ | ||
-1.86% | 148B | B | ||
+7.88% | 56.08B | D+ | ||
+4.19% | 32.39B | B+ | ||
-2.64% | 28.25B | C+ | ||
+68.62% | 22.8B | D+ | ||
+17.57% | 20.04B | B- | ||
+12.91% | 14.82B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- LSPK Stock
- Ratings LifeSpeak Inc.